phase 1_initiation

Gilead Sciences Inc — GS-1701 (Phase I Trial Initiation)

April 30, 2026$GILD GS-1701updated 4mo ago

community read0 votes

Therapy area: Infectious Disease. Indication: Unspecified Infectious Diseases

Data sources

globaldata

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?